Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-7 expression in serous ovarian carcinomas.

Anticancer research - 1 Apr 2015

Swiercz Aneta, Chechlinska Magdalena, Kupryjanczyk Jolanta, Dansonka-Mieszkowska Agnieszka, Rembiszewska Alina, Goryca Krzysztof, Kulinczak Mariusz, Zajdel Michalina, Sromek Maria, Siwicki Jan Konrad

Abstract excerpt

BACKGROUND/AIM: miR-7 has recently been linked to cancer. Some miR-7 targets, including B-cell lymphoma 2 (BCL2) and epidermal growth factor receptor (EGFR), are involved in ovarian cancer (OC) pathogenesis. The majority of OCs display TP53 mutations, which are critically important for OC develop...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to ErbB Receptors
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, bcl-2

Share to MicroRNAs

Share to Neoplasm Grading

Share to Ovarian Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 25862909

Genes

BCL2
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25862909-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-7 expression in serous ovarian carcinomas.PMID 25862909Read ↗

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.Semantic proximity Read ↗

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.Semantic proximity Read ↗

Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcomeSemantic proximity Read ↗

miR-6850 Drives Phenotypic Changes and Signaling in High Grade Serous Ovarian CancerSemantic proximity Read ↗

Expression signatures of TP53 mutations in serous ovarian cancers.Semantic proximity Read ↗

Immunohistochemical expression of p53 in Type I and II epithelial ovarian cancer among Sudanese women: a cross-sectional studySemantic proximity Read ↗

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.Semantic proximity Read ↗

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin.Semantic proximity Read ↗

A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors.Semantic proximity Read ↗

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian CancersSemantic proximity Read ↗

Prognostic and clinical significance of Solute Carrier Family 7 Member 1 in ovarian cancerSemantic proximity Read ↗

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.